Esprit
Device Vascular
PDI 08031527009162
General payments
$1,324,335
Research payments
$2,695,949
Through program year 2025, $1,324,335 in general payments and $2,695,949 in research payments were reported against Esprit (Vascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $855,230 | 4,862 |
| 2025 | Research | $1,731,596 | 865 |
| 2024 | General | $347,274 | 2,773 |
| 2024 | Research | $459,292 | 423 |
| 2023 | General | $94,527 | 42 |
| 2023 | Research | $502,226 | 404 |
| 2021 | General | $27,304 | 76 |
| 2021 | Research | $2,835 | 76 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 92 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
7,753 general · 1,768 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.